Horizon Discovery and AstraZeneca: searching for novel, personalised cancer therapies

At AstraZeneca, our bold ambition is to transform the lives of people with cancer and one day help to eliminate cancer as a cause of death.

A joint project plan agreed with Horizon Discovery, a Cambridge, UK-based translational genomics company, is ensuring that innovation is at the forefront of our collaboration. Our partnership uses cutting-edge science to develop advanced approaches to the treatment of cancer through a better understanding of the genetic basis of the disease.

 

 

Related articles